Plus Therapeutics reported $275K in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Baxter International USD 517M 549K Jun/2026
Dr.Reddys Laboratories INR 832.69M 176K Mar/2026
Haemonetics USD 45.47M 1.36M Jun/2026
Northwest Biotherapeutics USD 1.61B 88.6M Mar/2026
Plus Therapeutics USD 275K 138.4M Mar/2026
Sanofi EUR 1.21B 8.25M Mar/2026
Starpharma Holdings AUD 419.92M 179.17M Dec/2025
Sun Pharmaceuticals INR 2.4B 0 Mar/2026
Teva Pharmaceutical Industries USD 1.16B 1000K Jun/2026